אתר זה משתמש בעוגיות (Cookies) לשיפור חווית הגלישה.
לקריאת הצהרת הפרטיות שלנו.
In her current role in this internal-consulting group, She supports Pfizer's Biopharmaceutical Business by making strategic recommendations and tradeoffs within and across Pfizer's Drug Development Portfolio.
Her group uses innovative and transparent frameworks and methodologies to drive decision-making on internal assets and externally-sourced assets.
She has led a variety of teams and projects across the company and across multiple therapeutic areas including neuroscience, oncology, inflammation, and biosimilars.
She has extensive experience in product Lifecycle Planning, R&D Portfolio Prioritization, licensing and M&A.
Holds an MBA from the Johnson Business School at Cornell